Here are seven biopharma-related trends for 2026 that have emerged from GEN interviews with experts and other industry stakeholders, and from reviews of reports and public statements.

The central pathology of APOEε4 involves a vicious cycle of lipid metabolism disorders and neuroinflammation. Consequently, upregulating lipidation transporters, such as ABCA1, to improve APOEε4's ...

The world of medical testing is always changing, and point-of-care molecular diagnostics are a big part of that. These tests let us find out what’s going on with a patient’s health right there, ...

The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...

Scientists are using CRISPR to fast-track the domestication of a wild fruit. For roughly 10,000 years, farming communities ...

In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...

CRISPR is one of the most revolutionary technologies of the modern era, and now it's being used to bring back long-lost genes ...

Scientists have developed an experimental way to study how human embryos implant in a uterus, which may provide new insights into why miscarriages occur and how they can be prevented.

Large-scale human genetics studies have shown that many risk variants for common and complex diseases sit in the non-coding ...

The code of life is now editable and the question humanity must answer in the 2020s is not whether we can rewrite it—but whether we should, and for whom.

We are indeed still evolving, though it can be hard to tell because it happens over generations and often involves things you can't see, such as what foods different people are able to digest. When ...